Both in Biotechnology
INmune Bio vs ImageneBio
Over the past year INMB returned −15.9% and IMA returned −51.7%; their daily moves had a correlation of 0.18.
INMB −15.9% IMA −51.7%Growth of $1, one year, split-adjusted
| Metric | INMB | IMA |
|---|---|---|
| Price | $1.53 | $4.20 |
| Market cap | $42.5M | $47.7M |
| Today | +0.66% | +4.48% |
| 1 month | −21.9% | −8.3% |
| 6 months | +15.0% | −29.2% |
| Year to date | −1.9% | −39.1% |
| 1 year | −16.8% | −49.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $18.4M | $136.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 36.9% |
| Short % of float | 11.7% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).